Copyright
©The Author(s) 2016.
World J Transplant. Mar 24, 2016; 6(1): 249-254
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.249
Published online Mar 24, 2016. doi: 10.5500/wjt.v6.i1.249
Ref. | No. of patients | Type oftransplant | Age at transplantation(yr) | Donor | Post-transplant immunosuppressive drugs | Post-transplant complications | Outcomes |
O'Brien et al[5] | 1 | Single right | NA | NA | NA | NA | NA |
Bittmann et al[8,9] | 1 | Single right | 34 | Male Cadaveric | NA | Pneumothorax | Survival 2 yr COD: pneumothorax and hypoxemia |
Karbowniczek et al[1] | 1 | Single right | 42 | Male cadaveric | Cyclosporine, Azathioprine, Prednisone | Chylous pleural effusion | Survival 2 yr COD: Aspergillus pneumonia, |
Recurrence of LAM was confirmed on autopsy | |||||||
Chen et al[7] | 1 | Bilateral Living-donor lobar | 23 | Mother and sister | NA | Massive chylous pleural effusion and ascites | Not known, but she was diagnosed with recurrence of LAM in left lung 2 yr after transplantation due to characteristics cystic changes and pathological confirmation |
Sugimoto et al[6] | 1 | Bilateral Living-donor lobar | 23 | Brother | Tacrolimus, Prednisone | Un-eventful course | Dyspnea and pleural effusion following 5 yr post-transplant, sirolimus 1-2 mg/d helped resolve pleural effusion and improved lung function and symptoms |
Benden et al[10] | 4 | NA | NA | NA | Cyclosporine, Tacrolimus, Prednisone, Azathioprine | Surgical complications, respiratory tract infections, pneumothorax, pulmonary embolism | Not specified for recurrence of LAM, 5 yr survival was estimated to be 34% |
- Citation: Zaki KS, Aryan Z, Mehta AC, Akindipe O, Budev M. Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation. World J Transplant 2016; 6(1): 249-254
- URL: https://www.wjgnet.com/2220-3230/full/v6/i1/249.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i1.249